| 0 |
CILIARY BODY OPERATION |
11 |
1.0000 |
| 1 |
SCLEROTOMY |
5 |
0.8333 |
| 2 |
SCLERAL OPERATION |
4 |
0.5714 |
| 3 |
INTERNAL LIMITING MEMBRANE PEELING |
7 |
0.5385 |
| 4 |
TRABECULOPLASTY |
20 |
0.5128 |
| 5 |
POTASSIUM HYDROXIDE PREPARATION POSITIVE |
3 |
0.5000 |
| 6 |
GLAUCOMA DRAINAGE DEVICE PLACEMENT |
18 |
0.3103 |
| 7 |
TRABECULECTOMY |
24 |
0.2609 |
| 8 |
RETINAL LASER COAGULATION |
5 |
0.1852 |
| 9 |
DRUG IMPLANTATION |
2 |
0.1818 |
| 10 |
ANORECTAL INFECTION BACTERIAL |
2 |
0.1333 |
| 11 |
SKIN TEMPERATURE |
3 |
0.1304 |
| 12 |
IMPLANTATION COMPLICATION |
26 |
0.1250 |
| 13 |
OPHTHALMIC FLUID DRAINAGE |
3 |
0.1034 |
| 14 |
CORNEAL DECOMPENSATION |
16 |
0.0994 |
| 15 |
VITRECTOMY |
58 |
0.0973 |
| 16 |
MEDICAL DEVICE REPOSITIONING |
3 |
0.0938 |
| 17 |
HYPOTONY OF EYE |
39 |
0.0929 |
| 18 |
MEDICAL DEVICE REMOVAL |
108 |
0.0624 |
| 19 |
LENS EXTRACTION |
2 |
0.0526 |
| 20 |
OCULAR LYMPHOMA |
7 |
0.0496 |
| 21 |
MACULAR THICKENING |
4 |
0.0476 |
| 22 |
OPTIC NERVE CUPPING |
6 |
0.0472 |
| 23 |
BLOOD SMEAR TEST ABNORMAL |
3 |
0.0375 |
| 24 |
GLAUCOMA SURGERY |
9 |
0.0352 |
| 25 |
EPINEPHRINE INCREASED |
3 |
0.0333 |
| 26 |
CHORIORETINAL FOLDS |
2 |
0.0282 |
| 27 |
RETINITIS VIRAL |
3 |
0.0248 |
| 28 |
IRIS NEOVASCULARISATION |
3 |
0.0240 |
| 29 |
DIABETIC RETINAL OEDEMA |
12 |
0.0236 |
| 30 |
PATIENT UNCOOPERATIVE |
11 |
0.0232 |
| 31 |
INTRAOCULAR LENS IMPLANT |
11 |
0.0222 |
| 32 |
DRUG DELIVERY SYSTEM ISSUE |
43 |
0.0218 |
| 33 |
CORNEAL OEDEMA |
48 |
0.0214 |
| 34 |
RHEGMATOGENOUS RETINAL DETACHMENT |
4 |
0.0191 |
| 35 |
LENS DISLOCATION |
4 |
0.0190 |
| 36 |
OPTIC DISC DISORDER |
4 |
0.0190 |
| 37 |
INVESTIGATION NONCOMPLIANCE |
2 |
0.0183 |
| 38 |
RETINAL CYST |
3 |
0.0181 |
| 39 |
DEVICE DISPENSING ERROR |
19 |
0.0161 |
| 40 |
CHOROIDAL HAEMORRHAGE |
3 |
0.0155 |
| 41 |
INTRAOCULAR PRESSURE INCREASED |
198 |
0.0155 |
| 42 |
CHOROIDAL DETACHMENT |
8 |
0.0144 |
| 43 |
EPIRETINAL MEMBRANE |
4 |
0.0144 |
| 44 |
RETINAL OPERATION |
4 |
0.0143 |
| 45 |
NECROTISING RETINITIS |
9 |
0.0141 |
| 46 |
OCULAR HYPERTENSION |
27 |
0.0139 |
| 47 |
ERYTHEMA ANNULARE |
4 |
0.0138 |
| 48 |
RETINAL OCCLUSIVE VASCULITIS |
3 |
0.0134 |
| 49 |
ANTERIOR CHAMBER FLARE |
3 |
0.0129 |
| 50 |
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY |
3 |
0.0129 |
| 51 |
VITREOUS HAEMORRHAGE |
34 |
0.0123 |
| 52 |
EYE HAEMATOMA |
3 |
0.0114 |
| 53 |
EYE COMPLICATION ASSOCIATED WITH DEVICE |
3 |
0.0112 |
| 54 |
STEROID WITHDRAWAL SYNDROME |
11 |
0.0108 |
| 55 |
SUDDEN VISUAL LOSS |
3 |
0.0108 |
| 56 |
TOPICAL STEROID WITHDRAWAL REACTION |
4 |
0.0103 |
| 57 |
DEAFNESS PERMANENT |
2 |
0.0102 |
| 58 |
EYE LASER SURGERY |
6 |
0.0102 |
| 59 |
DEVICE FAILURE |
151 |
0.0099 |
| 60 |
BIRTH MARK |
2 |
0.0096 |
| 61 |
INJURY CORNEAL |
5 |
0.0096 |
| 62 |
INTRAOCULAR PRESSURE DECREASED |
5 |
0.0095 |
| 63 |
LASER THERAPY |
2 |
0.0089 |
| 64 |
MACULAR FIBROSIS |
6 |
0.0088 |
| 65 |
INTRA-OCULAR INJECTION COMPLICATION |
2 |
0.0088 |
| 66 |
POSTERIOR CAPSULE OPACIFICATION |
3 |
0.0087 |
| 67 |
EUSTACHIAN TUBE DYSFUNCTION |
5 |
0.0087 |
| 68 |
CYSTOID MACULAR OEDEMA |
16 |
0.0085 |
| 69 |
CREST SYNDROME |
2 |
0.0084 |
| 70 |
HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION |
3 |
0.0084 |
| 71 |
RETINAL DEGENERATION |
10 |
0.0077 |
| 72 |
CYTOMEGALOVIRUS CHORIORETINITIS |
15 |
0.0077 |
| 73 |
CHOROIDAL EFFUSION |
6 |
0.0075 |
| 74 |
BODY TINEA |
4 |
0.0071 |
| 75 |
HEPATITIS B SURFACE ANTIBODY POSITIVE |
2 |
0.0068 |
| 76 |
CATARACT OPERATION |
40 |
0.0067 |
| 77 |
LENTIGO |
3 |
0.0060 |
| 78 |
IRIS ADHESIONS |
3 |
0.0058 |
| 79 |
HYPHAEMA |
3 |
0.0057 |
| 80 |
XEROSIS |
7 |
0.0057 |
| 81 |
KERATOCONUS |
2 |
0.0053 |
| 82 |
HERPES OPHTHALMIC |
7 |
0.0053 |
| 83 |
HERPES SIMPLEX REACTIVATION |
2 |
0.0052 |
| 84 |
SUTURE INSERTION |
3 |
0.0051 |
| 85 |
DRUG DELIVERY SYSTEM MALFUNCTION |
26 |
0.0051 |
| 86 |
ADRENAL ADENOMA |
3 |
0.0050 |
| 87 |
ENDOPHTHALMITIS |
30 |
0.0050 |
| 88 |
MACULAR OEDEMA |
28 |
0.0050 |
| 89 |
SEBORRHOEIC KERATOSIS |
7 |
0.0048 |
| 90 |
EYE OPERATION |
22 |
0.0048 |
| 91 |
GLIOSIS |
2 |
0.0047 |
| 92 |
HAEMANGIOMA OF SKIN |
2 |
0.0046 |
| 93 |
KERATOACANTHOMA |
3 |
0.0044 |
| 94 |
BILIARY SEPSIS |
2 |
0.0043 |
| 95 |
ECZEMA HERPETICUM |
2 |
0.0043 |
| 96 |
VITRITIS |
8 |
0.0043 |
| 97 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
141 |
0.0042 |
| 98 |
OTITIS EXTERNA |
5 |
0.0041 |
| 99 |
STAPHYLOCOCCAL SKIN INFECTION |
5 |
0.0041 |
| 100 |
MICROALBUMINURIA |
3 |
0.0040 |
| 101 |
GLARE |
2 |
0.0039 |
| 102 |
CONJUNCTIVAL OEDEMA |
4 |
0.0039 |
| 103 |
EOSINOPHIL PERCENTAGE INCREASED |
2 |
0.0037 |
| 104 |
SKIN WEEPING |
13 |
0.0036 |
| 105 |
SEBORRHOEIC DERMATITIS |
6 |
0.0036 |
| 106 |
VITREOUS OPACITIES |
3 |
0.0036 |
| 107 |
HEPATITIS A |
3 |
0.0035 |
| 108 |
NON-INFECTIOUS ENDOPHTHALMITIS |
3 |
0.0035 |
| 109 |
LIFE EXPECTANCY SHORTENED |
2 |
0.0035 |
| 110 |
DEVICE DISLOCATION |
149 |
0.0034 |
| 111 |
PRODUCT ADMINISTRATION ERROR |
69 |
0.0034 |
| 112 |
ANTERIOR CHAMBER INFLAMMATION |
2 |
0.0034 |
| 113 |
NEEDLE ISSUE |
97 |
0.0033 |
| 114 |
CERUMEN IMPACTION |
3 |
0.0033 |
| 115 |
CORNEAL DISORDER |
7 |
0.0032 |
| 116 |
MEDICAL DEVICE IMPLANTATION |
5 |
0.0032 |
| 117 |
EYELID RASH |
3 |
0.0031 |
| 118 |
CATARACT NUCLEAR |
2 |
0.0030 |
| 119 |
GLAUCOMA |
57 |
0.0030 |
| 120 |
CYST RUPTURE |
2 |
0.0029 |
| 121 |
ANTERIOR CHAMBER CELL |
2 |
0.0028 |
| 122 |
GENITAL PAIN |
4 |
0.0027 |
| 123 |
HALO VISION |
3 |
0.0027 |
| 124 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
5 |
0.0026 |
| 125 |
CORNEAL TRANSPLANT |
2 |
0.0026 |
| 126 |
CUSHINGOID |
8 |
0.0025 |
| 127 |
SKIN EROSION |
8 |
0.0025 |
| 128 |
ALTERED VISUAL DEPTH PERCEPTION |
2 |
0.0024 |
| 129 |
GUTTATE PSORIASIS |
2 |
0.0024 |
| 130 |
RETINAL TEAR |
6 |
0.0024 |
| 131 |
HAND-FOOT-AND-MOUTH DISEASE |
2 |
0.0024 |
| 132 |
VITREOUS FLOATERS |
23 |
0.0023 |
| 133 |
ENDOCRINE OPHTHALMOPATHY |
2 |
0.0023 |
| 134 |
CYSTOCELE |
2 |
0.0023 |
| 135 |
PAPULE |
16 |
0.0023 |
| 136 |
SKIN PLAQUE |
19 |
0.0023 |
| 137 |
BLOOD ALBUMIN INCREASED |
2 |
0.0022 |
| 138 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
38 |
0.0022 |
| 139 |
CORNEAL OPACITY |
3 |
0.0022 |
| 140 |
CORNEAL ABRASION |
3 |
0.0022 |
| 141 |
RETINAL DETACHMENT |
20 |
0.0022 |
| 142 |
MACULE |
6 |
0.0022 |
| 143 |
CONJUNCTIVAL HAEMORRHAGE |
8 |
0.0021 |
| 144 |
VARICELLA |
5 |
0.0021 |
| 145 |
FOREIGN BODY IN EYE |
2 |
0.0021 |
| 146 |
MENTAL FATIGUE |
3 |
0.0020 |
| 147 |
EPICONDYLITIS |
3 |
0.0020 |
| 148 |
EYELID PAIN |
4 |
0.0020 |
| 149 |
ANAL PRURITUS |
4 |
0.0019 |
| 150 |
GASTROINTESTINAL VIRAL INFECTION |
2 |
0.0019 |
| 151 |
EAR SWELLING |
4 |
0.0019 |
| 152 |
ENTEROCOCCAL BACTERAEMIA |
2 |
0.0019 |
| 153 |
SCLERITIS |
3 |
0.0019 |
| 154 |
SKIN DISCOMFORT |
5 |
0.0019 |
| 155 |
EPSTEIN-BARR VIRAEMIA |
2 |
0.0018 |
| 156 |
SCRATCH |
19 |
0.0018 |
| 157 |
RHINITIS ALLERGIC |
8 |
0.0018 |
| 158 |
TEMPERATURE REGULATION DISORDER |
4 |
0.0018 |
| 159 |
DERMATITIS ATOPIC |
94 |
0.0018 |
| 160 |
SKIN HYPERTROPHY |
5 |
0.0018 |
| 161 |
ADMINISTRATION SITE PAIN |
2 |
0.0017 |
| 162 |
VITILIGO |
4 |
0.0017 |
| 163 |
LYMPHOPROLIFERATIVE DISORDER |
5 |
0.0017 |
| 164 |
PRURITUS GENITAL |
4 |
0.0017 |
| 165 |
INGROWING NAIL |
4 |
0.0017 |
| 166 |
EYE INFLAMMATION |
16 |
0.0017 |
| 167 |
EYELID SKIN DRYNESS |
2 |
0.0016 |
| 168 |
ESSENTIAL HYPERTENSION |
3 |
0.0016 |
| 169 |
DRUG DOSE TITRATION NOT PERFORMED |
3 |
0.0016 |
| 170 |
COMPLICATION OF DEVICE INSERTION |
32 |
0.0016 |
| 171 |
MELANOCYTIC NAEVUS |
7 |
0.0016 |
| 172 |
SNORING |
6 |
0.0016 |
| 173 |
LIP HAEMORRHAGE |
2 |
0.0016 |
| 174 |
HEPATOSPLENOMEGALY |
4 |
0.0016 |
| 175 |
HERPES SIMPLEX |
10 |
0.0015 |
| 176 |
ACROCHORDON |
2 |
0.0015 |
| 177 |
LIP EXFOLIATION |
2 |
0.0015 |
| 178 |
MENISCUS INJURY |
9 |
0.0015 |
| 179 |
JOINT INSTABILITY |
2 |
0.0014 |
| 180 |
OPTIC NEUROPATHY |
3 |
0.0014 |
| 181 |
LYMPHOCYTOSIS |
3 |
0.0014 |
| 182 |
INFUSION SITE BRUISING |
3 |
0.0014 |
| 183 |
VITREOUS DETACHMENT |
3 |
0.0014 |
| 184 |
EXCESSIVE EYE BLINKING |
2 |
0.0014 |
| 185 |
CONJUNCTIVITIS ALLERGIC |
2 |
0.0013 |
| 186 |
NEURODERMATITIS |
5 |
0.0013 |
| 187 |
ASTIGMATISM |
2 |
0.0013 |
| 188 |
KERATITIS |
4 |
0.0013 |
| 189 |
LICHEN PLANUS |
3 |
0.0013 |
| 190 |
THERAPEUTIC PRODUCT INEFFECTIVE |
5 |
0.0013 |
| 191 |
EYELIDS PRURITUS |
4 |
0.0013 |
| 192 |
KERATOPATHY |
2 |
0.0013 |
| 193 |
VISUAL FIELD DEFECT |
9 |
0.0012 |
| 194 |
AORTIC VALVE DISEASE |
2 |
0.0012 |
| 195 |
COLON CANCER METASTATIC |
2 |
0.0012 |
| 196 |
NEUROLOGICAL SYMPTOM |
7 |
0.0012 |
| 197 |
TRIGGER FINGER |
5 |
0.0012 |
| 198 |
SKIN ATROPHY |
7 |
0.0012 |
| 199 |
CATHETER SITE HAEMORRHAGE |
3 |
0.0012 |
| 200 |
EYELID IRRITATION |
3 |
0.0012 |
| 201 |
B-CELL LYMPHOMA |
4 |
0.0012 |
| 202 |
DEAFNESS BILATERAL |
2 |
0.0012 |
| 203 |
ANGLE CLOSURE GLAUCOMA |
3 |
0.0012 |
| 204 |
GAZE PALSY |
2 |
0.0012 |
| 205 |
ACUTE SINUSITIS |
2 |
0.0012 |
| 206 |
DERMATITIS |
24 |
0.0011 |
| 207 |
TYPE I HYPERSENSITIVITY |
4 |
0.0011 |
| 208 |
BREAST CYST |
2 |
0.0011 |
| 209 |
ECZEMA |
59 |
0.0011 |
| 210 |
SEBORRHOEA |
4 |
0.0011 |
| 211 |
DEAFNESS UNILATERAL |
6 |
0.0011 |
| 212 |
CEREBROSPINAL FLUID LEAKAGE |
2 |
0.0011 |
| 213 |
SKIN HAEMORRHAGE |
16 |
0.0011 |
| 214 |
ELECTRIC SHOCK SENSATION |
3 |
0.0011 |
| 215 |
SCAB |
12 |
0.0011 |
| 216 |
RETINAL VEIN OCCLUSION |
3 |
0.0010 |
| 217 |
SKIN SWELLING |
9 |
0.0010 |
| 218 |
VISUAL ACUITY REDUCED |
34 |
0.0010 |
| 219 |
SKIN FISSURES |
20 |
0.0010 |
| 220 |
PSORIASIS |
133 |
0.0010 |
| 221 |
BLINDNESS |
41 |
0.0010 |
| 222 |
SKIN PAPILLOMA |
4 |
0.0010 |
| 223 |
THROMBOPHLEBITIS SUPERFICIAL |
3 |
0.0010 |
| 224 |
EAR HAEMORRHAGE |
2 |
0.0010 |
| 225 |
EYE INJURY |
3 |
0.0010 |
| 226 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
4 |
0.0010 |
| 227 |
PIGMENTATION DISORDER |
6 |
0.0010 |
| 228 |
SCOLIOSIS |
6 |
0.0010 |
| 229 |
IRIDOCYCLITIS |
3 |
0.0009 |
| 230 |
SKIN EXFOLIATION |
80 |
0.0009 |
| 231 |
EYE CONTUSION |
2 |
0.0009 |
| 232 |
PROCTALGIA |
6 |
0.0009 |
| 233 |
BLOOD TESTOSTERONE INCREASED |
2 |
0.0009 |
| 234 |
CHAPPED LIPS |
4 |
0.0009 |
| 235 |
HENOCH-SCHONLEIN PURPURA |
2 |
0.0009 |
| 236 |
INFUSION SITE HAEMORRHAGE |
3 |
0.0009 |
| 237 |
SPINAL OSTEOARTHRITIS |
8 |
0.0009 |
| 238 |
ASTHENOPIA |
5 |
0.0009 |
| 239 |
COLONOSCOPY |
2 |
0.0009 |
| 240 |
GRAFT VERSUS HOST DISEASE IN SKIN |
2 |
0.0009 |
| 241 |
EAR DISCOMFORT |
9 |
0.0009 |
| 242 |
REGURGITATION |
3 |
0.0009 |
| 243 |
CONJUNCTIVITIS |
16 |
0.0009 |
| 244 |
ERYTHEMA MULTIFORME |
8 |
0.0009 |
| 245 |
DISCOMFORT |
52 |
0.0009 |
| 246 |
ESCHERICHIA BACTERAEMIA |
2 |
0.0008 |
| 247 |
SEASONAL ALLERGY |
12 |
0.0008 |
| 248 |
SPINAL COLUMN STENOSIS |
4 |
0.0008 |
| 249 |
MACULOPATHY |
3 |
0.0008 |
| 250 |
CONJUNCTIVAL HYPERAEMIA |
3 |
0.0008 |
| 251 |
MONOCYTE COUNT INCREASED |
3 |
0.0008 |
| 252 |
DERMAL CYST |
2 |
0.0008 |
| 253 |
EYE INFECTION |
9 |
0.0008 |
| 254 |
SWELLING OF EYELID |
5 |
0.0008 |
| 255 |
INFUSION SITE SWELLING |
5 |
0.0008 |
| 256 |
KLEBSIELLA INFECTION |
4 |
0.0008 |
| 257 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
3 |
0.0008 |
| 258 |
THYROID MASS |
3 |
0.0008 |
| 259 |
FOOD ALLERGY |
6 |
0.0008 |
| 260 |
ACTINIC KERATOSIS |
2 |
0.0008 |
| 261 |
WOUND SECRETION |
3 |
0.0008 |
| 262 |
EYE PAIN |
43 |
0.0008 |
| 263 |
SKIN DISCOLOURATION |
35 |
0.0008 |
| 264 |
HYPERPHAGIA |
3 |
0.0008 |
| 265 |
SKIN MASS |
5 |
0.0007 |
| 266 |
BLEPHARITIS |
3 |
0.0007 |
| 267 |
ALCOHOL ABUSE |
2 |
0.0007 |
| 268 |
EYE PRURITUS |
25 |
0.0007 |
| 269 |
BLOOD SODIUM INCREASED |
2 |
0.0007 |
| 270 |
CHEILITIS |
4 |
0.0007 |
| 271 |
ERYTHEMA OF EYELID |
4 |
0.0007 |
| 272 |
UVEITIS |
10 |
0.0007 |
| 273 |
SLEEP DISORDER |
52 |
0.0007 |
| 274 |
APPLICATION SITE HAEMORRHAGE |
2 |
0.0007 |
| 275 |
NO ADVERSE EVENT |
132 |
0.0007 |
| 276 |
ONYCHOCLASIS |
5 |
0.0007 |
| 277 |
RED CELL DISTRIBUTION WIDTH INCREASED |
3 |
0.0007 |
| 278 |
EAR PAIN |
14 |
0.0007 |
| 279 |
VITAMIN D DEFICIENCY |
7 |
0.0007 |
| 280 |
PRODUCT DOSE OMISSION ISSUE |
210 |
0.0007 |
| 281 |
SKIN REACTION |
10 |
0.0007 |
| 282 |
CATARACT |
42 |
0.0007 |
| 283 |
RETINAL HAEMORRHAGE |
5 |
0.0007 |
| 284 |
LIP PAIN |
2 |
0.0007 |
| 285 |
FIBULA FRACTURE |
2 |
0.0007 |
| 286 |
MUSCLE STRAIN |
6 |
0.0007 |
| 287 |
OFF LABEL USE |
606 |
0.0007 |
| 288 |
SKIN DISORDER |
23 |
0.0007 |
| 289 |
WHEELCHAIR USER |
3 |
0.0007 |
| 290 |
EYE HAEMORRHAGE |
9 |
0.0007 |
| 291 |
EAR DISORDER |
3 |
0.0007 |
| 292 |
APHTHOUS ULCER |
5 |
0.0006 |
| 293 |
ROSACEA |
3 |
0.0006 |
| 294 |
EAR INFECTION |
17 |
0.0006 |
| 295 |
SECRETION DISCHARGE |
8 |
0.0006 |
| 296 |
BLOOD CREATININE DECREASED |
2 |
0.0006 |
| 297 |
PHOTOPHOBIA |
12 |
0.0006 |
| 298 |
MULTIPLE ALLERGIES |
5 |
0.0006 |
| 299 |
DERMATITIS ALLERGIC |
8 |
0.0006 |
| 300 |
APPLICATION SITE PAIN |
14 |
0.0006 |
| 301 |
INFUSION SITE PRURITUS |
2 |
0.0006 |
| 302 |
FURUNCLE |
5 |
0.0006 |
| 303 |
VISUAL IMPAIRMENT |
78 |
0.0006 |
| 304 |
IMPAIRED QUALITY OF LIFE |
9 |
0.0006 |
| 305 |
DRY SKIN |
83 |
0.0006 |
| 306 |
RHINITIS |
5 |
0.0006 |
| 307 |
DERMATITIS CONTACT |
7 |
0.0006 |
| 308 |
LYMPHOCYTE COUNT INCREASED |
2 |
0.0006 |
| 309 |
PROTEIN URINE PRESENT |
3 |
0.0006 |
| 310 |
PRURITUS |
231 |
0.0006 |
| 311 |
HIGH DENSITY LIPOPROTEIN DECREASED |
2 |
0.0006 |
| 312 |
POST-TRAUMATIC STRESS DISORDER |
4 |
0.0006 |
| 313 |
DYSLIPIDAEMIA |
3 |
0.0006 |
| 314 |
APPLICATION SITE DRYNESS |
2 |
0.0006 |
| 315 |
HEPATIC CYST |
2 |
0.0006 |
| 316 |
BENIGN PROSTATIC HYPERPLASIA |
3 |
0.0006 |
| 317 |
TRISMUS |
3 |
0.0006 |
| 318 |
THERAPY NON-RESPONDER |
26 |
0.0006 |
| 319 |
DERMATITIS EXFOLIATIVE GENERALISED |
2 |
0.0006 |
| 320 |
RASH MACULAR |
20 |
0.0006 |
| 321 |
EAR PRURITUS |
2 |
0.0006 |
| 322 |
SENSITIVITY TO WEATHER CHANGE |
3 |
0.0006 |
| 323 |
HAND FRACTURE |
4 |
0.0006 |
| 324 |
DEVICE PLACEMENT ISSUE |
2 |
0.0006 |
| 325 |
INJECTION SITE DISCHARGE |
3 |
0.0006 |
| 326 |
SKIN CANCER |
12 |
0.0006 |
| 327 |
ANAL ABSCESS |
3 |
0.0006 |
| 328 |
SINUS DISORDER |
11 |
0.0006 |
| 329 |
FAECALOMA |
3 |
0.0005 |
| 330 |
PHOTOSENSITIVITY REACTION |
9 |
0.0005 |
| 331 |
SENSITIVE SKIN |
4 |
0.0005 |
| 332 |
HIATUS HERNIA |
7 |
0.0005 |
| 333 |
CANDIDA INFECTION |
9 |
0.0005 |
| 334 |
CHRONIC SINUSITIS |
2 |
0.0005 |
| 335 |
PULMONARY CONGESTION |
7 |
0.0005 |
| 336 |
PERONEAL NERVE PALSY |
3 |
0.0005 |
| 337 |
SLEEP APNOEA SYNDROME |
10 |
0.0005 |
| 338 |
HYPERTONIA |
3 |
0.0005 |
| 339 |
PAIN OF SKIN |
14 |
0.0005 |
| 340 |
DEVICE USE ISSUE |
9 |
0.0005 |
| 341 |
ORAL HERPES |
10 |
0.0005 |
| 342 |
PRODUCT ADMINISTRATION INTERRUPTED |
4 |
0.0005 |
| 343 |
DECREASED INTEREST |
3 |
0.0005 |
| 344 |
OCULAR HYPERAEMIA |
24 |
0.0005 |
| 345 |
BLADDER DISORDER |
5 |
0.0005 |
| 346 |
HYPERLIPIDAEMIA |
6 |
0.0005 |
| 347 |
CEREBRAL ATROPHY |
2 |
0.0005 |
| 348 |
HYPOTONIA |
5 |
0.0005 |
| 349 |
DRY EYE |
25 |
0.0005 |
| 350 |
DEVICE DIFFICULT TO USE |
33 |
0.0005 |
| 351 |
SQUAMOUS CELL CARCINOMA OF SKIN |
3 |
0.0005 |
| 352 |
FUNGAL SKIN INFECTION |
2 |
0.0005 |
| 353 |
INTERNATIONAL NORMALISED RATIO DECREASED |
2 |
0.0005 |
| 354 |
DERMATITIS ACNEIFORM |
3 |
0.0005 |
| 355 |
APPLICATION SITE PRURITUS |
11 |
0.0005 |
| 356 |
INJECTION SITE DISCOLOURATION |
6 |
0.0005 |
| 357 |
NASAL DRYNESS |
3 |
0.0005 |
| 358 |
THERAPEUTIC RESPONSE DECREASED |
29 |
0.0005 |
| 359 |
BLEPHAROSPASM |
3 |
0.0005 |
| 360 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
2 |
0.0005 |
| 361 |
SENSATION OF FOREIGN BODY |
4 |
0.0005 |
| 362 |
PHOTOPSIA |
3 |
0.0005 |
| 363 |
DRUG DOSE OMISSION BY DEVICE |
37 |
0.0005 |
| 364 |
DRUG EFFECT LESS THAN EXPECTED |
7 |
0.0005 |
| 365 |
AORTIC VALVE INCOMPETENCE |
2 |
0.0005 |
| 366 |
INTERVERTEBRAL DISC DISORDER |
2 |
0.0005 |
| 367 |
SKIN HYPERPIGMENTATION |
4 |
0.0005 |
| 368 |
PHARYNGITIS STREPTOCOCCAL |
5 |
0.0005 |
| 369 |
SKIN LACERATION |
5 |
0.0005 |
| 370 |
REFUSAL OF TREATMENT BY PATIENT |
3 |
0.0005 |
| 371 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
4 |
0.0005 |
| 372 |
URINE OUTPUT DECREASED |
4 |
0.0005 |
| 373 |
DIVERTICULUM INTESTINAL |
2 |
0.0005 |
| 374 |
PRODUCT PREPARATION ISSUE |
3 |
0.0005 |
| 375 |
NAIL DISORDER |
4 |
0.0005 |
| 376 |
TOOTH INFECTION |
6 |
0.0005 |
| 377 |
WALKING AID USER |
3 |
0.0005 |
| 378 |
SARS-COV-2 TEST POSITIVE |
6 |
0.0005 |
| 379 |
IRON DEFICIENCY |
2 |
0.0004 |
| 380 |
COLITIS ISCHAEMIC |
3 |
0.0004 |
| 381 |
MITRAL VALVE INCOMPETENCE |
5 |
0.0004 |
| 382 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
2 |
0.0004 |
| 383 |
HAEMOGLOBIN INCREASED |
2 |
0.0004 |
| 384 |
MICTURITION URGENCY |
5 |
0.0004 |
| 385 |
SKIN LESION |
12 |
0.0004 |
| 386 |
SKIN IRRITATION |
20 |
0.0004 |
| 387 |
FORMICATION |
3 |
0.0004 |
| 388 |
LACRIMATION INCREASED |
13 |
0.0004 |
| 389 |
CARPAL TUNNEL SYNDROME |
6 |
0.0004 |
| 390 |
PRODUCT QUALITY ISSUE |
58 |
0.0004 |
| 391 |
FLANK PAIN |
4 |
0.0004 |
| 392 |
ARTERIOSCLEROSIS |
4 |
0.0004 |
| 393 |
PRODUCT DOSE OMISSION IN ERROR |
12 |
0.0004 |
| 394 |
FEAR OF INJECTION |
3 |
0.0004 |
| 395 |
PSORIATIC ARTHROPATHY |
17 |
0.0004 |
| 396 |
INCREASED APPETITE |
8 |
0.0004 |
| 397 |
RASH ERYTHEMATOUS |
20 |
0.0004 |
| 398 |
HEPATITIS C |
5 |
0.0004 |
| 399 |
BURSITIS |
5 |
0.0004 |
| 400 |
NEURALGIA |
10 |
0.0004 |
| 401 |
HAEMORRHOIDS |
8 |
0.0004 |
| 402 |
PHARYNGEAL SWELLING |
4 |
0.0004 |
| 403 |
BLINDNESS TRANSIENT |
3 |
0.0004 |
| 404 |
RASH |
177 |
0.0004 |
| 405 |
ARTHROPOD BITE |
3 |
0.0004 |
| 406 |
FOOT OPERATION |
2 |
0.0004 |
| 407 |
CYST |
5 |
0.0004 |
| 408 |
SUNBURN |
3 |
0.0004 |
| 409 |
INJECTION SITE INFLAMMATION |
2 |
0.0004 |
| 410 |
SYRINGE ISSUE |
7 |
0.0004 |
| 411 |
DERMATITIS EXFOLIATIVE |
2 |
0.0004 |
| 412 |
EYE IRRITATION |
23 |
0.0004 |
| 413 |
BREAST TENDERNESS |
3 |
0.0004 |
| 414 |
EYE DISORDER |
13 |
0.0004 |
| 415 |
OSTEOPENIA |
6 |
0.0004 |
| 416 |
AORTIC ANEURYSM |
3 |
0.0004 |
| 417 |
DRY THROAT |
4 |
0.0004 |
| 418 |
BOWEL MOVEMENT IRREGULARITY |
3 |
0.0004 |
| 419 |
PROCEDURAL COMPLICATION |
3 |
0.0004 |
| 420 |
UPPER RESPIRATORY TRACT INFECTION |
18 |
0.0004 |
| 421 |
HAEMOLYSIS |
3 |
0.0004 |
| 422 |
LOW DENSITY LIPOPROTEIN INCREASED |
3 |
0.0004 |
| 423 |
RASH PRURITIC |
21 |
0.0004 |
| 424 |
EYE DISCHARGE |
4 |
0.0004 |
| 425 |
GASTROINTESTINAL INFLAMMATION |
3 |
0.0004 |
| 426 |
PRODUCT ODOUR ABNORMAL |
4 |
0.0004 |
| 427 |
PRODUCT USE COMPLAINT |
6 |
0.0004 |
| 428 |
INCONTINENCE |
4 |
0.0004 |
| 429 |
NASAL DISCOMFORT |
3 |
0.0004 |
| 430 |
TRICUSPID VALVE INCOMPETENCE |
3 |
0.0004 |
| 431 |
GINGIVAL PAIN |
3 |
0.0004 |
| 432 |
BREAST PAIN |
4 |
0.0004 |
| 433 |
ANAL FISTULA |
2 |
0.0004 |
| 434 |
NASAL CONGESTION |
22 |
0.0004 |
| 435 |
HAIR TEXTURE ABNORMAL |
5 |
0.0004 |
| 436 |
POOR QUALITY SLEEP |
8 |
0.0004 |
| 437 |
GINGIVITIS |
2 |
0.0004 |
| 438 |
LYMPHADENOPATHY |
13 |
0.0004 |
| 439 |
IMPAIRED GASTRIC EMPTYING |
5 |
0.0004 |
| 440 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
26 |
0.0004 |
| 441 |
STAPHYLOCOCCAL INFECTION |
12 |
0.0004 |
| 442 |
INTESTINAL ISCHAEMIA |
2 |
0.0004 |
| 443 |
HYPERKERATOSIS |
2 |
0.0004 |
| 444 |
HUNGER |
5 |
0.0004 |
| 445 |
DEVICE ISSUE |
32 |
0.0004 |
| 446 |
SKIN INFECTION |
4 |
0.0004 |
| 447 |
OCULAR DISCOMFORT |
4 |
0.0004 |
| 448 |
INFUSION SITE ERYTHEMA |
3 |
0.0004 |
| 449 |
ERYTHEMA |
73 |
0.0004 |
| 450 |
BLINDNESS UNILATERAL |
5 |
0.0004 |
| 451 |
BLOOD PRESSURE ABNORMAL |
7 |
0.0004 |
| 452 |
ALOPECIA |
69 |
0.0004 |
| 453 |
SKIN ULCER |
9 |
0.0003 |
| 454 |
EXERCISE TOLERANCE DECREASED |
2 |
0.0003 |
| 455 |
DEVICE DEFECTIVE |
6 |
0.0003 |
| 456 |
DYSPHONIA |
20 |
0.0003 |
| 457 |
LUNG INFILTRATION |
3 |
0.0003 |
| 458 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
3 |
0.0003 |
| 459 |
BRADYKINESIA |
2 |
0.0003 |
| 460 |
COVID-19 PNEUMONIA |
4 |
0.0003 |
| 461 |
BLISTER |
19 |
0.0003 |
| 462 |
BRONCHITIS |
25 |
0.0003 |
| 463 |
PRODUCT USE IN UNAPPROVED INDICATION |
83 |
0.0003 |
| 464 |
MYOSITIS |
3 |
0.0003 |
| 465 |
HEARING IMPAIRED |
2 |
0.0003 |
| 466 |
IRRITABILITY |
20 |
0.0003 |
| 467 |
SWELLING |
31 |
0.0003 |
| 468 |
INJECTION SITE VESICLES |
2 |
0.0003 |
| 469 |
CORONARY ARTERY DISEASE |
10 |
0.0003 |
| 470 |
ECONOMIC PROBLEM |
5 |
0.0003 |
| 471 |
ACNE |
25 |
0.0003 |
| 472 |
ADRENAL INSUFFICIENCY |
4 |
0.0003 |
| 473 |
INFLAMMATION |
17 |
0.0003 |
| 474 |
HIDRADENITIS |
3 |
0.0003 |
| 475 |
EXOSTOSIS |
3 |
0.0003 |
| 476 |
BURNING SENSATION |
23 |
0.0003 |
| 477 |
JOINT INJURY |
7 |
0.0003 |
| 478 |
BRAIN NEOPLASM |
3 |
0.0003 |
| 479 |
MIGRAINE |
31 |
0.0003 |
| 480 |
CONCOMITANT DISEASE AGGRAVATED |
2 |
0.0003 |
| 481 |
GENERALISED OEDEMA |
4 |
0.0003 |
| 482 |
PHARYNGITIS |
4 |
0.0003 |
| 483 |
INFUSION SITE EXTRAVASATION |
2 |
0.0003 |
| 484 |
FOREIGN BODY SENSATION IN EYES |
2 |
0.0003 |
| 485 |
ORAL PAIN |
7 |
0.0003 |
| 486 |
CONDITION AGGRAVATED |
95 |
0.0003 |
| 487 |
ATELECTASIS |
3 |
0.0003 |
| 488 |
INFUSION SITE PAIN |
4 |
0.0003 |
| 489 |
DEEP VEIN THROMBOSIS |
20 |
0.0003 |
| 490 |
ANGINA UNSTABLE |
2 |
0.0003 |
| 491 |
BACK DISORDER |
5 |
0.0003 |
| 492 |
NODULE |
4 |
0.0003 |
| 493 |
RENAL TUBULAR NECROSIS |
3 |
0.0003 |
| 494 |
THERAPY CHANGE |
3 |
0.0003 |
| 495 |
HYPOGAMMAGLOBULINAEMIA |
2 |
0.0003 |
| 496 |
HAEMATOCRIT DECREASED |
6 |
0.0003 |
| 497 |
ARTERIOSCLEROSIS CORONARY ARTERY |
2 |
0.0003 |
| 498 |
ILLNESS |
31 |
0.0003 |
| 499 |
FUNGAL INFECTION |
10 |
0.0003 |
| 500 |
DEVICE MALFUNCTION |
21 |
0.0003 |
| 501 |
QUALITY OF LIFE DECREASED |
4 |
0.0003 |
| 502 |
DYSPNOEA EXERTIONAL |
11 |
0.0003 |
| 503 |
ECCHYMOSIS |
2 |
0.0003 |
| 504 |
PERIPHERAL COLDNESS |
4 |
0.0003 |
| 505 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
4 |
0.0003 |
| 506 |
DROOLING |
2 |
0.0003 |
| 507 |
LARGE INTESTINE POLYP |
2 |
0.0003 |
| 508 |
PULMONARY HYPERTENSION |
6 |
0.0003 |
| 509 |
LARGE INTESTINE PERFORATION |
2 |
0.0003 |
| 510 |
PETECHIAE |
3 |
0.0003 |
| 511 |
EXTRASYSTOLES |
2 |
0.0003 |
| 512 |
MOUTH ULCERATION |
6 |
0.0003 |
| 513 |
BLOOD TRIGLYCERIDES INCREASED |
5 |
0.0003 |
| 514 |
CLOSTRIDIUM DIFFICILE COLITIS |
3 |
0.0003 |
| 515 |
PAIN IN JAW |
8 |
0.0003 |
| 516 |
RETCHING |
6 |
0.0003 |
| 517 |
BRONCHOSPASM |
4 |
0.0003 |
| 518 |
HEREDITARY ANGIOEDEMA |
3 |
0.0003 |
| 519 |
GASTROENTERITIS VIRAL |
5 |
0.0003 |
| 520 |
OEDEMA |
15 |
0.0003 |
| 521 |
FAECES SOFT |
2 |
0.0003 |
| 522 |
LIQUID PRODUCT PHYSICAL ISSUE |
2 |
0.0003 |
| 523 |
SUICIDAL IDEATION |
25 |
0.0003 |
| 524 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
5 |
0.0003 |
| 525 |
GASTROINTESTINAL PAIN |
3 |
0.0003 |
| 526 |
TOOTH FRACTURE |
3 |
0.0003 |
| 527 |
THERAPEUTIC RESPONSE SHORTENED |
9 |
0.0003 |
| 528 |
EXPIRED PRODUCT ADMINISTERED |
9 |
0.0003 |
| 529 |
NERVE INJURY |
3 |
0.0003 |
| 530 |
EYE SWELLING |
10 |
0.0003 |
| 531 |
URTICARIA |
45 |
0.0003 |
| 532 |
PULMONARY MASS |
4 |
0.0003 |
| 533 |
IMMUNODEFICIENCY |
4 |
0.0003 |
| 534 |
DEAFNESS |
7 |
0.0003 |
| 535 |
RASH PAPULAR |
6 |
0.0003 |
| 536 |
HYDRONEPHROSIS |
2 |
0.0003 |
| 537 |
REBOUND EFFECT |
3 |
0.0003 |
| 538 |
SUICIDE ATTEMPT |
16 |
0.0003 |
| 539 |
POLLAKIURIA |
11 |
0.0003 |
| 540 |
ROAD TRAFFIC ACCIDENT |
11 |
0.0003 |
| 541 |
INFECTION |
38 |
0.0003 |
| 542 |
VISION BLURRED |
36 |
0.0003 |
| 543 |
INSURANCE ISSUE |
4 |
0.0003 |
| 544 |
NEOPLASM |
3 |
0.0003 |
| 545 |
FREQUENT BOWEL MOVEMENTS |
7 |
0.0003 |
| 546 |
THROAT TIGHTNESS |
7 |
0.0003 |
| 547 |
MADAROSIS |
3 |
0.0003 |
| 548 |
VASCULITIS |
3 |
0.0003 |
| 549 |
BASAL CELL CARCINOMA |
4 |
0.0003 |
| 550 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
14 |
0.0003 |
| 551 |
AFFECTIVE DISORDER |
2 |
0.0003 |
| 552 |
ULCER |
4 |
0.0003 |
| 553 |
OBESITY |
4 |
0.0003 |
| 554 |
DEMENTIA |
7 |
0.0003 |
| 555 |
BLOOD DISORDER |
2 |
0.0002 |
| 556 |
NIGHT SWEATS |
8 |
0.0002 |
| 557 |
LIVER DISORDER |
11 |
0.0002 |
| 558 |
FLATULENCE |
14 |
0.0002 |
| 559 |
NO THERAPEUTIC RESPONSE |
3 |
0.0002 |
| 560 |
INTENTIONAL DOSE OMISSION |
7 |
0.0002 |
| 561 |
DECUBITUS ULCER |
2 |
0.0002 |
| 562 |
THROAT IRRITATION |
11 |
0.0002 |
| 563 |
HYPERSOMNIA |
7 |
0.0002 |
| 564 |
ABNORMAL FAECES |
2 |
0.0002 |
| 565 |
SMALL INTESTINAL OBSTRUCTION |
3 |
0.0002 |
| 566 |
IMPAIRED HEALING |
8 |
0.0002 |
| 567 |
SPINAL OPERATION |
3 |
0.0002 |
| 568 |
HYPERAESTHESIA |
2 |
0.0002 |
| 569 |
ESCHERICHIA INFECTION |
2 |
0.0002 |
| 570 |
TENDON RUPTURE |
3 |
0.0002 |
| 571 |
HAIR COLOUR CHANGES |
3 |
0.0002 |
| 572 |
VIRAL INFECTION |
8 |
0.0002 |
| 573 |
NEPHROLITHIASIS |
11 |
0.0002 |
| 574 |
CELLULITIS |
12 |
0.0002 |
| 575 |
SKIN BURNING SENSATION |
17 |
0.0002 |
| 576 |
CHRONIC KIDNEY DISEASE |
18 |
0.0002 |
| 577 |
MUSCLE ATROPHY |
3 |
0.0002 |
| 578 |
INJECTION SITE IRRITATION |
3 |
0.0002 |
| 579 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
4 |
0.0002 |
| 580 |
ANOREXIA |
3 |
0.0002 |
| 581 |
INJECTION SITE REACTION |
16 |
0.0002 |
| 582 |
MUSCULOSKELETAL DISCOMFORT |
4 |
0.0002 |
| 583 |
ANURIA |
2 |
0.0002 |
| 584 |
BLOOD MAGNESIUM DECREASED |
2 |
0.0002 |
| 585 |
EXPOSURE VIA SKIN CONTACT |
6 |
0.0002 |
| 586 |
DIPLOPIA |
6 |
0.0002 |
| 587 |
PRODUCT PRESCRIBING ISSUE |
5 |
0.0002 |
| 588 |
INTERVERTEBRAL DISC PROTRUSION |
5 |
0.0002 |
| 589 |
JOINT STIFFNESS |
6 |
0.0002 |
| 590 |
CONTUSION |
22 |
0.0002 |
| 591 |
BEDRIDDEN |
3 |
0.0002 |
| 592 |
NASOPHARYNGITIS |
42 |
0.0002 |
| 593 |
ORAL CANDIDIASIS |
3 |
0.0002 |
| 594 |
COLD SWEAT |
4 |
0.0002 |
| 595 |
DYSMENORRHOEA |
3 |
0.0002 |
| 596 |
SINUSITIS |
23 |
0.0002 |
| 597 |
INFLUENZA |
25 |
0.0002 |
| 598 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
10 |
0.0002 |
| 599 |
SNEEZING |
5 |
0.0002 |
| 600 |
URINARY TRACT INFECTION |
38 |
0.0002 |
| 601 |
BLOOD BILIRUBIN INCREASED |
6 |
0.0002 |
| 602 |
SINUS CONGESTION |
3 |
0.0002 |
| 603 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
40 |
0.0002 |
| 604 |
INJECTION SITE SWELLING |
17 |
0.0002 |
| 605 |
HEART RATE IRREGULAR |
5 |
0.0002 |
| 606 |
LIMB INJURY |
6 |
0.0002 |
| 607 |
LIP DRY |
2 |
0.0002 |
| 608 |
BALANCE DISORDER |
19 |
0.0002 |
| 609 |
BONE DISORDER |
4 |
0.0002 |
| 610 |
MUSCLE TWITCHING |
5 |
0.0002 |
| 611 |
RHINORRHOEA |
14 |
0.0002 |
| 612 |
INTERVERTEBRAL DISC DEGENERATION |
2 |
0.0002 |
| 613 |
MEDICATION ERROR |
12 |
0.0002 |
| 614 |
ORAL DISCOMFORT |
3 |
0.0002 |
| 615 |
FEELING COLD |
6 |
0.0002 |
| 616 |
APHONIA |
3 |
0.0002 |
| 617 |
HEPATIC STEATOSIS |
4 |
0.0002 |
| 618 |
PRODUCT DOSE OMISSION |
14 |
0.0002 |
| 619 |
APPENDICITIS |
2 |
0.0002 |
| 620 |
DEFORMITY |
2 |
0.0002 |
| 621 |
PAIN IN EXTREMITY |
63 |
0.0002 |
| 622 |
ABDOMINAL PAIN UPPER |
44 |
0.0002 |
| 623 |
BLOOD TEST ABNORMAL |
3 |
0.0002 |
| 624 |
COVID-19 |
37 |
0.0002 |
| 625 |
ABDOMINAL DISTENSION |
22 |
0.0002 |
| 626 |
BLOOD URINE PRESENT |
4 |
0.0002 |
| 627 |
PRODUCTIVE COUGH |
10 |
0.0002 |
| 628 |
ARTHRALGIA |
87 |
0.0002 |
| 629 |
PULMONARY FIBROSIS |
4 |
0.0002 |
| 630 |
DRUG PRESCRIBING ERROR |
4 |
0.0002 |
| 631 |
ACUTE RESPIRATORY FAILURE |
4 |
0.0002 |
| 632 |
DIARRHOEA |
134 |
0.0002 |
| 633 |
HYPERCHOLESTEROLAEMIA |
2 |
0.0002 |
| 634 |
DIZZINESS POSTURAL |
2 |
0.0002 |
| 635 |
GASTROENTERITIS |
3 |
0.0002 |
| 636 |
OROPHARYNGEAL PAIN |
19 |
0.0002 |
| 637 |
HYPERSENSITIVITY |
38 |
0.0002 |
| 638 |
KIDNEY INFECTION |
4 |
0.0002 |
| 639 |
COUGH |
57 |
0.0002 |
| 640 |
HOSPICE CARE |
2 |
0.0002 |
| 641 |
EXTRAPYRAMIDAL DISORDER |
5 |
0.0002 |
| 642 |
PERIPHERAL SWELLING |
31 |
0.0002 |
| 643 |
THERAPEUTIC RESPONSE UNEXPECTED |
9 |
0.0002 |
| 644 |
DRUG INEFFECTIVE |
264 |
0.0002 |
| 645 |
PAIN |
123 |
0.0002 |
| 646 |
SPINAL FRACTURE |
4 |
0.0002 |
| 647 |
BONE LOSS |
3 |
0.0002 |
| 648 |
EXTRA DOSE ADMINISTERED |
8 |
0.0002 |
| 649 |
FEEDING DISORDER |
4 |
0.0002 |
| 650 |
NECK PAIN |
11 |
0.0002 |
| 651 |
EYELID PTOSIS |
2 |
0.0002 |
| 652 |
HEADACHE |
123 |
0.0002 |
| 653 |
THERAPY INTERRUPTED |
14 |
0.0002 |
| 654 |
TINNITUS |
9 |
0.0002 |
| 655 |
HYPOPHAGIA |
5 |
0.0002 |
| 656 |
EUPHORIC MOOD |
2 |
0.0002 |
| 657 |
INITIAL INSOMNIA |
2 |
0.0002 |
| 658 |
ERECTILE DYSFUNCTION |
5 |
0.0002 |
| 659 |
LIMB DISCOMFORT |
6 |
0.0002 |
| 660 |
MUSCULAR WEAKNESS |
22 |
0.0002 |
| 661 |
INJECTION SITE PAIN |
59 |
0.0002 |
| 662 |
BRAIN FOG |
3 |
0.0002 |
| 663 |
FOLLICULITIS |
2 |
0.0002 |
| 664 |
ANHEDONIA |
5 |
0.0002 |
| 665 |
INJECTION SITE DISCOMFORT |
2 |
0.0002 |
| 666 |
BACK PAIN |
44 |
0.0002 |
| 667 |
PNEUMOTHORAX |
3 |
0.0002 |
| 668 |
OSTEOARTHRITIS |
8 |
0.0002 |
| 669 |
SCIATICA |
3 |
0.0002 |
| 670 |
BODY HEIGHT DECREASED |
2 |
0.0002 |
| 671 |
HOT FLUSH |
14 |
0.0002 |
| 672 |
MUSCLE TIGHTNESS |
3 |
0.0002 |
| 673 |
BIPOLAR DISORDER |
2 |
0.0002 |
| 674 |
BACK INJURY |
2 |
0.0002 |
| 675 |
CHOLELITHIASIS |
6 |
0.0002 |
| 676 |
INTENTIONAL PRODUCT MISUSE |
16 |
0.0002 |
| 677 |
INJECTION SITE NODULE |
2 |
0.0002 |
| 678 |
BLOOD PRESSURE DECREASED |
12 |
0.0002 |
| 679 |
OEDEMA PERIPHERAL |
22 |
0.0002 |
| 680 |
FOOT DEFORMITY |
2 |
0.0002 |
| 681 |
DEPRESSION |
41 |
0.0002 |
| 682 |
LIP SWELLING |
6 |
0.0002 |
| 683 |
MENTAL STATUS CHANGES |
5 |
0.0002 |
| 684 |
TRANSAMINASES INCREASED |
4 |
0.0002 |
| 685 |
RASH MACULO-PAPULAR |
4 |
0.0002 |
| 686 |
INJECTION SITE PRURITUS |
12 |
0.0002 |
| 687 |
WEIGHT DECREASED |
50 |
0.0002 |
| 688 |
PANCYTOPENIA |
10 |
0.0002 |
| 689 |
PULMONARY OEDEMA |
8 |
0.0002 |
| 690 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0002 |
| 691 |
TARDIVE DYSKINESIA |
5 |
0.0002 |
| 692 |
CHROMATURIA |
4 |
0.0002 |
| 693 |
FLUSHING |
18 |
0.0002 |
| 694 |
ASTHMA |
20 |
0.0002 |
| 695 |
IMPAIRED DRIVING ABILITY |
2 |
0.0002 |
| 696 |
RED BLOOD CELL COUNT DECREASED |
5 |
0.0002 |
| 697 |
CONSTIPATION |
38 |
0.0002 |
| 698 |
HERPES ZOSTER |
10 |
0.0002 |
| 699 |
LIVER FUNCTION TEST ABNORMAL |
5 |
0.0002 |
| 700 |
UNEVALUABLE EVENT |
13 |
0.0002 |
| 701 |
BLOOD CHOLESTEROL INCREASED |
8 |
0.0002 |
| 702 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
5 |
0.0002 |
| 703 |
SURGERY |
10 |
0.0002 |
| 704 |
MYALGIA |
29 |
0.0002 |
| 705 |
HYPOXIA |
6 |
0.0002 |
| 706 |
HEAD DISCOMFORT |
3 |
0.0002 |
| 707 |
SWELLING FACE |
11 |
0.0002 |
| 708 |
BACTERAEMIA |
2 |
0.0002 |
| 709 |
DISEASE RECURRENCE |
8 |
0.0002 |
| 710 |
ACCIDENT |
2 |
0.0002 |
| 711 |
ABDOMINAL DISCOMFORT |
28 |
0.0002 |
| 712 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
8 |
0.0002 |
| 713 |
DRUG INTOLERANCE |
16 |
0.0002 |
| 714 |
LOCALISED INFECTION |
4 |
0.0002 |
| 715 |
INSOMNIA |
44 |
0.0002 |
| 716 |
PANIC ATTACK |
6 |
0.0002 |
| 717 |
RESTLESSNESS |
6 |
0.0002 |
| 718 |
INJECTION SITE URTICARIA |
4 |
0.0002 |
| 719 |
RECTAL HAEMORRHAGE |
7 |
0.0002 |
| 720 |
ENCEPHALOPATHY |
4 |
0.0002 |
| 721 |
CARDIOMEGALY |
2 |
0.0002 |
| 722 |
EMOTIONAL DISORDER |
5 |
0.0002 |
| 723 |
ABNORMAL WEIGHT GAIN |
2 |
0.0002 |
| 724 |
GASTROOESOPHAGEAL REFLUX DISEASE |
13 |
0.0002 |
| 725 |
SEPSIS |
18 |
0.0002 |
| 726 |
APPLICATION SITE IRRITATION |
2 |
0.0002 |
| 727 |
MIDDLE INSOMNIA |
3 |
0.0002 |
| 728 |
AGEUSIA |
4 |
0.0002 |
| 729 |
DRY MOUTH |
13 |
0.0002 |
| 730 |
HEPATIC CIRRHOSIS |
3 |
0.0002 |
| 731 |
PRODUCT USE ISSUE |
30 |
0.0002 |
| 732 |
FOOT FRACTURE |
3 |
0.0002 |
| 733 |
DYSPHAGIA |
15 |
0.0002 |
| 734 |
HEAD INJURY |
5 |
0.0002 |
| 735 |
GASTRIC ULCER |
3 |
0.0002 |
| 736 |
FEELING JITTERY |
3 |
0.0002 |
| 737 |
FLUID RETENTION |
8 |
0.0002 |
| 738 |
LETHARGY |
9 |
0.0002 |
| 739 |
DIZZINESS |
78 |
0.0002 |
| 740 |
GASTROINTESTINAL DISORDER |
14 |
0.0002 |
| 741 |
HIP FRACTURE |
5 |
0.0002 |
| 742 |
FATIGUE |
121 |
0.0002 |
| 743 |
ERUCTATION |
3 |
0.0002 |
| 744 |
ANXIETY |
44 |
0.0002 |
| 745 |
RASH GENERALISED |
4 |
0.0002 |
| 746 |
CHOKING |
3 |
0.0002 |
| 747 |
BLOOD CREATININE INCREASED |
10 |
0.0002 |
| 748 |
MUSCULOSKELETAL PAIN |
8 |
0.0002 |
| 749 |
MUSCLE SPASMS |
28 |
0.0002 |
| 750 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
3 |
0.0002 |
| 751 |
DISORIENTATION |
6 |
0.0002 |
| 752 |
PNEUMONIA |
48 |
0.0001 |
| 753 |
TRANSIENT ISCHAEMIC ATTACK |
5 |
0.0001 |
| 754 |
PLEURAL EFFUSION |
9 |
0.0001 |
| 755 |
NEUROPATHY PERIPHERAL |
14 |
0.0001 |
| 756 |
DRUG TOXICITY |
2 |
0.0001 |
| 757 |
HYPERTENSION |
31 |
0.0001 |
| 758 |
PRODUCT PREPARATION ERROR |
3 |
0.0001 |
| 759 |
OSTEOPOROSIS |
6 |
0.0001 |
| 760 |
DIVERTICULITIS |
4 |
0.0001 |
| 761 |
HYPOMAGNESAEMIA |
2 |
0.0001 |
| 762 |
WOUND |
4 |
0.0001 |
| 763 |
GAIT DISTURBANCE |
27 |
0.0001 |
| 764 |
DIALYSIS |
2 |
0.0001 |
| 765 |
VOMITING |
66 |
0.0001 |
| 766 |
IMPAIRED WORK ABILITY |
3 |
0.0001 |
| 767 |
HYPOAESTHESIA |
21 |
0.0001 |
| 768 |
ANGINA PECTORIS |
4 |
0.0001 |
| 769 |
WEIGHT INCREASED |
31 |
0.0001 |
| 770 |
FAECES DISCOLOURED |
3 |
0.0001 |
| 771 |
MEMORY IMPAIRMENT |
19 |
0.0001 |
| 772 |
INJECTION SITE BRUISING |
11 |
0.0001 |
| 773 |
CRYING |
5 |
0.0001 |
| 774 |
HYPERGLYCAEMIA |
5 |
0.0001 |
| 775 |
MUSCULOSKELETAL STIFFNESS |
12 |
0.0001 |
| 776 |
CHILLS |
16 |
0.0001 |
| 777 |
ASCITES |
4 |
0.0001 |
| 778 |
INJECTION SITE MASS |
5 |
0.0001 |
| 779 |
URINARY INCONTINENCE |
4 |
0.0001 |
| 780 |
WHEEZING |
8 |
0.0001 |
| 781 |
COLON CANCER |
2 |
0.0001 |
| 782 |
NERVOUSNESS |
7 |
0.0001 |
| 783 |
ADVERSE DRUG REACTION |
12 |
0.0001 |
| 784 |
ATRIAL FIBRILLATION |
13 |
0.0001 |
| 785 |
DECREASED APPETITE |
31 |
0.0001 |
| 786 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 787 |
APHASIA |
4 |
0.0001 |
| 788 |
DYSPEPSIA |
13 |
0.0001 |
| 789 |
ASPARTATE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 790 |
PRODUCT AVAILABILITY ISSUE |
3 |
0.0001 |
| 791 |
ACUTE KIDNEY INJURY |
20 |
0.0001 |
| 792 |
FEELING HOT |
8 |
0.0001 |
| 793 |
PERICARDIAL EFFUSION |
3 |
0.0001 |
| 794 |
ANKLE FRACTURE |
2 |
0.0001 |
| 795 |
ABDOMINAL PAIN |
30 |
0.0001 |
| 796 |
NAUSEA |
102 |
0.0001 |
| 797 |
RENAL DISORDER |
6 |
0.0001 |
| 798 |
DELUSION |
2 |
0.0001 |
| 799 |
LUNG INFECTION |
2 |
0.0001 |
| 800 |
CHEST DISCOMFORT |
13 |
0.0001 |
| 801 |
HAEMATOCHEZIA |
7 |
0.0001 |
| 802 |
ANAPHYLACTIC REACTION |
7 |
0.0001 |
| 803 |
PULMONARY EMBOLISM |
12 |
0.0001 |
| 804 |
PRODUCT PRESCRIBING ERROR |
3 |
0.0001 |
| 805 |
ARTHROPATHY |
7 |
0.0001 |
| 806 |
CYSTITIS |
4 |
0.0001 |
| 807 |
ABSCESS |
2 |
0.0001 |
| 808 |
HYPOTHYROIDISM |
4 |
0.0001 |
| 809 |
METABOLIC ACIDOSIS |
4 |
0.0001 |
| 810 |
BLOOD PRESSURE INCREASED |
19 |
0.0001 |
| 811 |
PYREXIA |
43 |
0.0001 |
| 812 |
FIBROMYALGIA |
3 |
0.0001 |
| 813 |
FALL |
41 |
0.0001 |
| 814 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 815 |
DEVICE BREAKAGE |
5 |
0.0001 |
| 816 |
DYSKINESIA |
5 |
0.0001 |
| 817 |
LUNG NEOPLASM MALIGNANT |
5 |
0.0001 |
| 818 |
PRODUCT SUBSTITUTION ISSUE |
7 |
0.0001 |
| 819 |
INFLUENZA LIKE ILLNESS |
10 |
0.0001 |
| 820 |
FEELING ABNORMAL |
29 |
0.0001 |
| 821 |
INJECTION SITE ERYTHEMA |
15 |
0.0001 |
| 822 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 823 |
TREATMENT FAILURE |
10 |
0.0001 |
| 824 |
CYTOMEGALOVIRUS INFECTION |
2 |
0.0001 |
| 825 |
COAGULOPATHY |
2 |
0.0001 |
| 826 |
URINARY RETENTION |
4 |
0.0001 |
| 827 |
ASTHENIA |
45 |
0.0001 |
| 828 |
BONE PAIN |
7 |
0.0001 |
| 829 |
TYPE 2 DIABETES MELLITUS |
4 |
0.0001 |
| 830 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 831 |
HAEMOGLOBIN DECREASED |
12 |
0.0001 |
| 832 |
DRUG RESISTANCE |
3 |
0.0001 |
| 833 |
GASTRIC DISORDER |
4 |
0.0001 |
| 834 |
JOINT SWELLING |
14 |
0.0001 |
| 835 |
STOMATITIS |
7 |
0.0001 |
| 836 |
RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 837 |
SEPTIC SHOCK |
5 |
0.0001 |
| 838 |
MENTAL DISORDER |
5 |
0.0001 |
| 839 |
HAEMORRHAGE |
12 |
0.0001 |
| 840 |
LOCAL SWELLING |
2 |
0.0001 |
| 841 |
APPLICATION SITE ERYTHEMA |
3 |
0.0001 |
| 842 |
EOSINOPHILIA |
2 |
0.0001 |
| 843 |
ALANINE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 844 |
MALAISE |
50 |
0.0001 |
| 845 |
GASTRITIS |
3 |
0.0001 |
| 846 |
HEART RATE DECREASED |
4 |
0.0001 |
| 847 |
DEPRESSED MOOD |
6 |
0.0001 |
| 848 |
DRUG ERUPTION |
2 |
0.0001 |
| 849 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
8 |
0.0001 |
| 850 |
BREAST CANCER FEMALE |
3 |
0.0001 |
| 851 |
GALLBLADDER DISORDER |
2 |
0.0001 |
| 852 |
DRUG EFFECT DECREASED |
6 |
0.0001 |
| 853 |
DISTURBANCE IN ATTENTION |
6 |
0.0001 |
| 854 |
WHITE BLOOD CELL COUNT DECREASED |
12 |
0.0001 |
| 855 |
HOSPITALISATION |
17 |
0.0001 |
| 856 |
COMPLICATION OF DEVICE REMOVAL |
2 |
0.0001 |
| 857 |
LEUKOCYTOSIS |
2 |
0.0001 |
| 858 |
TREATMENT NONCOMPLIANCE |
6 |
0.0001 |
| 859 |
HYPERHIDROSIS |
14 |
0.0001 |
| 860 |
TREMOR |
18 |
0.0001 |
| 861 |
BLOOD GLUCOSE ABNORMAL |
2 |
0.0001 |
| 862 |
PROCEDURAL PAIN |
3 |
0.0001 |
| 863 |
COGNITIVE DISORDER |
5 |
0.0001 |
| 864 |
EPISTAXIS |
8 |
0.0001 |
| 865 |
ACCIDENTAL EXPOSURE TO PRODUCT |
11 |
0.0001 |
| 866 |
DYSARTHRIA |
4 |
0.0001 |
| 867 |
FEBRILE NEUTROPENIA |
7 |
0.0001 |
| 868 |
COLITIS |
4 |
0.0001 |
| 869 |
NEOPLASM MALIGNANT |
7 |
0.0001 |
| 870 |
MULTIPLE SCLEROSIS |
5 |
0.0001 |
| 871 |
WHITE BLOOD CELL COUNT INCREASED |
4 |
0.0001 |
| 872 |
BLOOD GLUCOSE DECREASED |
5 |
0.0001 |
| 873 |
LOWER LIMB FRACTURE |
2 |
0.0001 |
| 874 |
CHEST PAIN |
19 |
0.0001 |
| 875 |
PALPITATIONS |
12 |
0.0001 |
| 876 |
DISABILITY |
2 |
0.0001 |
| 877 |
RENAL INJURY |
3 |
0.0001 |
| 878 |
RESPIRATORY DISORDER |
3 |
0.0001 |
| 879 |
LEUKOPENIA |
5 |
0.0001 |
| 880 |
BLOOD POTASSIUM DECREASED |
3 |
0.0001 |
| 881 |
CYTOKINE RELEASE SYNDROME |
2 |
0.0001 |
| 882 |
CARDIAC FAILURE CONGESTIVE |
8 |
0.0001 |
| 883 |
INJURY |
7 |
0.0001 |
| 884 |
EMOTIONAL DISTRESS |
12 |
0.0001 |
| 885 |
CONTRAINDICATED PRODUCT ADMINISTERED |
3 |
0.0001 |
| 886 |
VERTIGO |
6 |
0.0001 |
| 887 |
INJURY ASSOCIATED WITH DEVICE |
2 |
0.0001 |
| 888 |
NEUTROPHIL COUNT DECREASED |
4 |
0.0001 |
| 889 |
RENAL FAILURE |
13 |
0.0001 |
| 890 |
DRUG ADMINISTRATION ERROR |
3 |
0.0001 |
| 891 |
DEHYDRATION |
13 |
0.0001 |
| 892 |
FEMUR FRACTURE |
3 |
0.0001 |
| 893 |
SWOLLEN TONGUE |
3 |
0.0001 |
| 894 |
SPEECH DISORDER |
5 |
0.0001 |
| 895 |
PARAESTHESIA |
15 |
0.0001 |
| 896 |
EATING DISORDER |
2 |
0.0001 |
| 897 |
MOVEMENT DISORDER |
3 |
0.0001 |
| 898 |
IRRITABLE BOWEL SYNDROME |
2 |
0.0001 |
| 899 |
CONFUSIONAL STATE |
15 |
0.0001 |
| 900 |
INCORRECT DOSE ADMINISTERED |
21 |
0.0001 |
| 901 |
DYSPNOEA |
52 |
0.0001 |
| 902 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
0.0001 |
| 903 |
HEART RATE INCREASED |
9 |
0.0001 |
| 904 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 905 |
SYNCOPE |
9 |
0.0001 |
| 906 |
MATERNAL EXPOSURE DURING PREGNANCY |
8 |
0.0001 |
| 907 |
HYPOTENSION |
18 |
0.0001 |
| 908 |
SOMNOLENCE |
18 |
0.0001 |
| 909 |
ARTHRITIS |
7 |
0.0001 |
| 910 |
OXYGEN SATURATION DECREASED |
5 |
0.0001 |
| 911 |
HYPONATRAEMIA |
5 |
0.0001 |
| 912 |
NEUTROPENIA |
12 |
0.0001 |
| 913 |
LOWER RESPIRATORY TRACT INFECTION |
4 |
0.0001 |
| 914 |
HAEMATURIA |
3 |
0.0001 |
| 915 |
CARDIAC FAILURE |
7 |
0.0001 |
| 916 |
NIGHTMARE |
3 |
0.0001 |
| 917 |
HYPOKALAEMIA |
4 |
0.0001 |
| 918 |
HYPERKALAEMIA |
3 |
0.0001 |
| 919 |
BLOOD GLUCOSE INCREASED |
16 |
0.0001 |
| 920 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
3 |
0.0001 |
| 921 |
PLATELET COUNT DECREASED |
9 |
0.0001 |
| 922 |
CEREBRAL HAEMORRHAGE |
3 |
0.0001 |
| 923 |
MOBILITY DECREASED |
6 |
0.0001 |
| 924 |
BLOOD PRESSURE FLUCTUATION |
2 |
0.0001 |
| 925 |
DIABETIC KETOACIDOSIS |
2 |
0.0001 |
| 926 |
DRUG EFFECT INCOMPLETE |
3 |
0.0001 |
| 927 |
HYPOGLYCAEMIA |
4 |
0.0001 |
| 928 |
C-REACTIVE PROTEIN INCREASED |
3 |
0.0001 |
| 929 |
ILL-DEFINED DISORDER |
5 |
0.0001 |
| 930 |
LUNG DISORDER |
4 |
0.0001 |
| 931 |
DYSURIA |
3 |
0.0001 |
| 932 |
AGGRESSION |
4 |
0.0001 |
| 933 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
2 |
0.0001 |
| 934 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
16 |
0.0001 |
| 935 |
DIABETES MELLITUS |
6 |
0.0001 |
| 936 |
ANAEMIA |
15 |
0.0001 |
| 937 |
DRUG DOSE OMISSION |
13 |
0.0001 |
| 938 |
LOSS OF CONSCIOUSNESS |
10 |
0.0001 |
| 939 |
GENERAL PHYSICAL HEALTH DETERIORATION |
9 |
0.0001 |
| 940 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
4 |
0.0001 |
| 941 |
DISEASE PROGRESSION |
9 |
0.0001 |
| 942 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 943 |
INJECTION SITE HAEMORRHAGE |
6 |
0.0001 |
| 944 |
JAUNDICE |
2 |
0.0001 |
| 945 |
THROMBOCYTOPENIA |
8 |
0.0001 |
| 946 |
WITHDRAWAL SYNDROME |
3 |
0.0001 |
| 947 |
INCORRECT DRUG ADMINISTRATION DURATION |
2 |
0.0001 |
| 948 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 949 |
CONVULSION |
4 |
0.0001 |
| 950 |
HYPOACUSIS |
3 |
0.0001 |
| 951 |
PRODUCT STORAGE ERROR |
6 |
0.0001 |
| 952 |
INTENTIONAL PRODUCT USE ISSUE |
6 |
0.0001 |
| 953 |
AGITATION |
5 |
0.0001 |
| 954 |
ANGIOEDEMA |
3 |
0.0001 |
| 955 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 956 |
TACHYCARDIA |
6 |
0.0001 |
| 957 |
HEPATIC FAILURE |
2 |
0.0001 |
| 958 |
INJECTION SITE RASH |
2 |
0.0001 |
| 959 |
EXPOSURE DURING PREGNANCY |
4 |
0.0001 |
| 960 |
CARDIAC DISORDER |
6 |
0.0001 |
| 961 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 962 |
ARRHYTHMIA |
3 |
0.0001 |
| 963 |
THROMBOSIS |
5 |
0.0001 |
| 964 |
LACTIC ACIDOSIS |
2 |
0.0001 |
| 965 |
AMNESIA |
4 |
0.0001 |
| 966 |
INFUSION RELATED REACTION |
4 |
0.0001 |
| 967 |
GAIT INABILITY |
2 |
0.0001 |
| 968 |
ANGER |
2 |
0.0001 |
| 969 |
HEPATIC ENZYME INCREASED |
4 |
0.0001 |
| 970 |
PANCREATITIS |
3 |
0.0001 |
| 971 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 972 |
BREAST CANCER |
5 |
0.0001 |
| 973 |
HEPATIC FUNCTION ABNORMAL |
2 |
0.0001 |
| 974 |
HALLUCINATION |
4 |
0.0001 |
| 975 |
GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0000 |
| 976 |
CARDIO-RESPIRATORY ARREST |
2 |
0.0000 |
| 977 |
RENAL IMPAIRMENT |
4 |
0.0000 |
| 978 |
MYOCARDIAL INFARCTION |
8 |
0.0000 |
| 979 |
DRUG WITHDRAWAL SYNDROME |
4 |
0.0000 |
| 980 |
MULTIPLE SCLEROSIS RELAPSE |
3 |
0.0000 |
| 981 |
SEIZURE |
5 |
0.0000 |
| 982 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 983 |
UNDERDOSE |
3 |
0.0000 |
| 984 |
DYSGEUSIA |
3 |
0.0000 |
| 985 |
MALIGNANT NEOPLASM PROGRESSION |
4 |
0.0000 |
| 986 |
BRADYCARDIA |
2 |
0.0000 |
| 987 |
CEREBROVASCULAR ACCIDENT |
6 |
0.0000 |
| 988 |
ADVERSE EVENT |
3 |
0.0000 |
| 989 |
DEATH |
22 |
0.0000 |
| 990 |
FOETAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 991 |
CARDIAC ARREST |
2 |
0.0000 |
| 992 |
DRUG ABUSE |
2 |
0.0000 |
| 993 |
DRUG INTERACTION |
3 |
0.0000 |